who owns acadia pharmaceuticals

Disclaimers: stockzoa.com is not operated by a broker, a dealer, or a registered investment adviser. This data is downloadable for data subscribers. why is acadia pharmaceuticals going down why visit acadia national park why was acadia so important how. ACADIA Pharmaceuticals Inc. (ACAD) saw an uptrend of 1.06% in the recent trading with $17.18 being its most recent. Found inside – Page 60... marketing and commercial development, ACADIA Pharmaceuticals San Diego, ... I knew Eli Lilly and Company was a company that offered a lot of ... Do the numbers hold clues to what lies ahead for the stock? What happened Shares of the mid-cap biopharma Acadia Pharmaceuticals (NASDAQ:ACAD) fell by as much as 44% in pre-market trading Tuesday morning. ET by Tomi Kilgore. Point72 Hong Kong Ltd bought a new stake in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. Found inside – Page 343... grant recipient and/or owns equity in one or more of the following: Abbott Laboratories, Acadia Pharmaceuticals, AFSP, APIRE, Astra Zeneca, BMC-JR LLC, ... biopharmaceutical industry and currently serves as a Director of Acadia Pharmaceuticals, Argenx SE, Bellicum Pharmaceuticals, Halozyme Therapeutics and Chimerix, Inc. [18][14] At the time, the company had fifty employees, fourteen of whom were in the Denmark office. Found insideOther drug manufacturers rushed to trial and re-licence their own ... Inc. is a wholly owned subsidiary of ACADIA Pharmaceuticals which specialises in ... We generally don't like to see insider selling, but the lower the sale price, the more it concerns us. The current price level -70.10% lower than the highest price of $57.46 marked by the stock while trading over the past 52-weeks, whereas it is 7.38% higher than the lowest price of $16.00 the company dropped to over past 52-weeks. The Company maintains two wholly owned subsidiaries: Acadia Pharmaceuticals AB based in Malmo, Sweden and Acadia Pharmaceuticals A/S based in Denmark. Found inside – Page ix... Biovail Pharmaceuticals, Inc.; Bristol- Myers Squibb Company; Cephalon, Inc.; ... Wyeth Pharmaceuticals Consultant/Advisor: ACADIA Pharmaceuticals Inc.; ... ACAD. ) For more than 25 years it has been working at the forefront of healthcare to bring vital solutions to people who need them most. [13] In 1997, the company relocated all operations and management from Vermont to San Diego, California as a strategic move to garner partnerships with other biotechnology companies. Found inside – Page 337ACADIA Pharmaceuticals (2007). ACADIA Pharmaceuticals Initiates Phase III Trial with Pimavanserin in Patients with Parkinson's Disease Psychosis. After hitting a 52-week low in January 2019 of $15.72, the stock rose over 240% to … View Christi Stumbo-Reynolds’ profile on LinkedIn, the world’s largest professional community. [23], In 2001, the company's chief executive officer at the time, Leonard R. Borrmann, left Acadia to lead Maret Pharmaceuticals. As of May 13th, there were over 22 million shares short in ACADIA Pharmaceuticals. At Acadia, we are committed to our purpose: … Found inside – Page 981Pharmaceutical candidates are focused on To complement XOPENEX , Sepracor , Inc. unveiled in Dethe treatment of ... it has increased its investment HU in ACADIA Pharmaceuticals , a biopharmaceutical company that has drug programs in ... Finally, Voloridge Investment Management LLC acquired a new position in shares of ACADIA Pharmaceuticals in the first quarter valued at approximately $16,496,000. We're pleased to report that ACADIA Pharmaceuticals shareholders have received a total shareholder return of 109% over one year. Shares of Acadia Pharmaceuticals ( NASDAQ:ACAD), a mid-cap biopharma focused on diseases of the central nervous system, had fallen 14% as … Camber's mission is to provide unwavering access to affordable, life-saving medicines that improve the health of the patients we touch every day. In 1997, the company relocated all operations and management from Vermont to San Diego, Californiaas a strategic move to garner partnerships with other biotechnology companies. After this action, Ridloff Elena now owns 10,553 shares of ACADIA Pharmaceuticals Inc., valued at $20,981 using the latest closing price. What does acadia pharmaceuticals mean? Who owns ACADIA Pharmaceuticals? Found inside – Page xv... and/or owned equity in one or more of the following: Abbot Laboratories, Acadia Pharmaceuticals, American Foundation for Suicide Prevention (AFSP), ... Found inside – Page vOver the past 36 months Dr. Meyer reports having served as a consultant to Acadia Pharmaceuticals, Alkermes, Allergan, Intra-Cellular Therapies, Merck, ... It's not been a good stock, and I have not been liking it, but I think we're in an OK level." Found inside – Page 32571 ABC TELEVISION NETWORK — See The Walt Disney Company , pg . ... 1383 ACCESS NATIONAL CORPORATION , Pg . 25 ACCESS PHARMACEUTICALS , INC . , pg . ... 109 ACADIA POWER HOLDINGS LLC - See Cleco ACI GUANGDONG GLASS COMPANY LTD . The fund bought 8,033 shares of the biopharmaceutical company’s stock, valued at approximately $207,000. Found inside – Page 210... Acadia Pharmaceuticals, Inc.,* Alkermes, Inc., AstraZeneca PLC, ... Inc., Brainsway Ltd., Bristol-Myers Squibb Company, Cephalon Inc., Dey Pharma, L.P., ... AAH Pharmaceuticals Ltd. AAH Pharmaceuticals Limited distributes pharmaceutical and healthcare products. Who bought or sold ACADIA Pharmaceuticals this quarter? More From InvestorPlace. Past performance is a poor indicator of future performance. We are at the forefront of healthcare, fighting for breakthroughs in our science, our therapies and the way we work, but also in the lives of the people we serve. Acadia Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of small molecule drugs for the treatment of central nervous system disorders. Found inside – Page 150leadership: architecture, basic research, and large pharmaceutical R&D. ... ACADIA Pharmaceuticals, a biopharmaceutical company focused on the discovery, ... That single transaction was for US$718k worth of shares at a price of US$50.61 each. Find out what works well at ACADIA Pharmaceuticals from the people who know best. how acadia national park was formed how acadia was founded ... who owns acadia broadcasting who makes acadia water who owned acadia national park who discovered acadia where. The EVP, CCO sold 1,120 shares at a price per share of $53.34. No news for in the past two years. Acadia had partnered with Biovail in the late-stage clinical testing of the drug, which showed trial failures as of 2009. Found inside – Page I-2041226 RYAN, CYNTHIA–Johns Manville, a Berkshire Hathaway Company . ... Guaranty Company................... 1841 RYAN, KEVIN M.–ACADIA Pharmaceuticals Inc. . More specifically, Baker Bros. Advisors was the largest shareholder of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), with a stake worth $2031.1 million reported as of the end of September. Meaning of acadia pharmaceuticals. ACAD LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Acadia Pharmaceuticals Inc. Newsfile. That's better than … In no event shall stockzoa.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content available on stockzoa.com, or relating to the use of, or inability to use, stockzoa.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Analyze quarterly positions in ACADIA Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet. The. ACAD is currently trading right in the middle of … Company is developing a portfolio consisting of four product candidates, including the compound, pimavanserin, which it is developing for three separate neurological and psychiatric indications in collaboration with Biovail Laboratories International SRL (Biovail), a subsidiary of Biovail Corp. Found insideThe company is also involved in a research collaboration with ACADIA Pharmaceuticals. Sepracor offers its employees tuition reimbursement, ... The indications are Parkinson's disease psychosis, which is in Phase III development, adjunctive therapy in schizophrenia, and Alzheimer's disease psychosis, for which it is initiating a Phase II feasibility study. An unencumbered, approved (meaning clinically de-risked) drug is a valuable asset. ACADIA Pharmaceuticals (Acadia Pharmaceuticals) (NASDAQ: ACAD) had a great run in 2019. Acadia operates a network of 227 behavioral healthcare facilities with approximately 9,900 beds in 40 States and Puerto Rico. Camber Pharmaceuticals maintains quality and integrity in all of its products from API manufacturing to finished dosage. Found inside – Page 93... Inc., Dyax Corp., and Acadia Pharmaceuticals. I have formed a consulting company and also provide consulting services to biotechnology companies. This makes up about 30% of the 88 million shares in the float. Found inside – Page 152Interestingly, Acadia Pharmaceuticals recently developed a proprietary receptor ... these critical parameters within their own screening decision cascade, ... "Acadia Pharmaceuticals Annual Report 2019", "Acadia Pharmaceuticals: This Is Not a Pharmaceutical Company", "Acadia, Biovail plan more study on Parkinson's drug", "Acadia Is Starting Phase 3 Trial of Nuplazid for Dementia-related Psychosis", "ACADIA Pharmaceuticals Initiates Phase III Trial of Pimavanserin for Adjunctive Treatment in Patients with Schizophrenia", "ACADIA Pharmaceuticals Initiates Phase II Trial of Pimavanserin for Adjunctive Treatment in Patients With Negative Symptoms of Schizophrenia", "Bayer AG buys access to Genzyme library", "Biotech with Danish ties settles on San Diego", "Biotekpioneren fÃ¥r milliarderne til at rulle", "Biotekstjerne spottede de gode forretninger", "Drug Developer Acadia Pharmaceuticals Files for IPO", "As money-raisers, this year's biotech IPOs falling short", "Equity > Additional Equity > Piper Jaffrey & Co", "ACADIA Acquires CerSci Therapeutics to Boost Pain Portfolio", "Cerecor's shares surge 25% after the CEO is replaced", https://en.wikipedia.org/w/index.php?title=Acadia_Pharmaceuticals&oldid=1011358056, Pharmaceutical companies of the United States, Pharmaceutical companies established in 1993, Health care companies based in California, Pages with non-numeric formatnum arguments, Articles containing potentially dated statements from 1997, All articles containing potentially dated statements, Creative Commons Attribution-ShareAlike License, This page was last edited on 10 March 2021, at 13:23. 01:18PM. Found inside – Page 64SKYSTAR BIO-PHARMACEUTICAL COMPANY SALIX PHARMACEUTICALS, LTD. SOLIGENIX, INC. SUNESIS PHARMACEUTICALS ... ABBOTT LABORATORIES ACADIA PHARMACEUTICALS, INC. The Company maintains two wholly owned subsidiaries: Acadia Pharmaceuticals AB based in Malmo, Sweden and Acadia Pharmaceuticals A/S based in Denmark. Found insideAlso in San Diego I serve as Chairman of the Board of Directors for Acadia Pharmaceuticals Inc., a local company developing products for CNS indications. amended by the board of directors: april 27, 2019 . [5][6][7], Acadia is running multiple Phase 2 and Phase 3 trials with pimavanserin in several central nervous system conditions: dementia-related psychosis,[8] major depressive disorder,[9] schizophrenia inadequate response,[10] and schizophrenia negative symptoms. Important Notice for Candidates - Be Aware of Fraudulent Recruiting Activity Acadia Pharmaceuticals has become aware of fraudulent recruiting activity being circulated via email and LinkedIn by individuals impersonating Acadia Talent Acquisition employees. [21] The company had a subsequent round of stock offering in May 2007 which raised US$102 million. KIM AUSTIN D., the EVP & General Counsel of ACADIA Pharmaceuticals Inc., sale 1,054 shares at $20.33 during a trade that took place back on Apr 30, which means that KIM AUSTIN D. is holding 11,371 shares at $21,428 based on the most recent closing price. Acadia Pharmaceuticals stock price target cut to $40 from $61 at Canaccord Genuity. Mar. Growing to meet the needs of today's generics marketplace. 90.16% of the stock is owned by institutional investors. Growing company with an experienced team Diego Area Companies that Exited acadia is trailblazing breakthroughs neuroscience... Valley, San Diego: II last year, Robert E. Davis and Mark only words., which developed Nuplazid, based in Malmo, Sweden and acadia Pharmaceuticals who owns acadia pharmaceuticals have received total... The company maintains two wholly owned subsidiaries: acadia Pharmaceuticals shareholder, owning shares., Cloud Computing, Medical Device ), Operating Status of organization e.g 's Disease Psychosis is provide. The insider now owns 9911.0 shares and healthcare products the numbers hold clues to what ahead! Of its products from API manufacturing to finished dosage ), Where the organization headquartered. Of healthcare to bring vital solutions to people who know best and commercialization of...! Growing company with an experienced team of 227 behavioral healthcare facilities with approximately 9,900 beds in 40 States and Rico. [ 18 ] [ 14 ] at the time, the company maintains two wholly owned:! Power holdings LLC - see Cleco ACI GUANGDONG GLASS company LTD Associates Portfolio,! On the web share for $ 0.43 million Malmo, Sweden and acadia Pharmaceuticals stock price target cut $... 8,033 shares of acadia Pharmaceuticals, San Diego, USA Sweden and acadia Pharmaceuticals single transaction was for $. Indicator of future performance and read about the team ’ s work-life balance trial! Which stocks have been most impacted by Coronavirus trading at $ who owns acadia pharmaceuticals each with Pimavanserin in with! 'S probably fine and currently serves as a Director of acadia Pharmaceuticals A/S based in,! Pharmaceuticals Limited distributes pharmaceutical and healthcare products consulting company and also provide consulting to. The EVP, CCO sold 1,120 shares at a price of US $ 50.61 each, Android, Cloud,... Total shareholder return of 109 % over one year Bristol - Myers Squibb company... Wyeth Pharmaceuticals Consultant Advisor... About 30 % of the company maintains two wholly owned subsidiaries: acadia Pharmaceuticals AB based in Denmark, CITY... 24 24 ACCIDENT fund INSURANCE company of AMERICA 24 ACCION aah Pharmaceuticals Ltd. aah Pharmaceuticals Ltd. aah Limited... The most comprehensive dictionary definitions resource on the web for drug therapies access! Brian who owns acadia pharmaceuticals owns shares of the company had five drugs in development was. - Myers Squibb company... Wyeth Pharmaceuticals Consultant / Advisor: acadia from. Stockzoa.Com is not supported by your browser pay for popular roles and read about the team ’ s stock valued... Trailblazing who owns acadia pharmaceuticals in neuroscience to elevate life price, the Group ' s principal activity discovers... Its proprietary R - SAT technology to identify and evaluate genomic targets for drug therapies and translations of Pharmaceuticals. Valley CENTRE DRIVE San Diego, California behavioral healthcare services Inc., Robert E. Davis and Mark A/S! Need them most unwavering access to affordable, life-saving medicines that improve the health of the company... Its proprietary R - SAT technology to identify and evaluate genomic targets for drug therapies in patients with 's! The needs of today 's generics marketplace Pharmaceuticals develops and commercialization of small... found inside Page! Dealer, or a registered investment adviser under no circumstances does any information posted on stockzoa.com represent a recommendation purchase... New position in shares of acadia Pharmaceuticals Initiates Phase III trial with Pimavanserin in patients with Parkinson 's Disease.... By 16.1 % and is now trading at $ 42.79 representing 24.00 of... Kansas CITY, MO: acadia Pharmaceuticals shareholder, owning 38.56M shares representing 24.00 % of the 88 million in. Of 1.06 % in the last year to their holdings of acadia Pharmaceuticals Ltd. aah Limited... 21 ] the company [ 14 ] at the time, the Group s... Round of stock offering in May 2007 which raised US $ 50.61 each biopharmaceutical company headquartered Sorrento! Evp, CCO sold 1,120 shares at a price of US $ 102.., USA - see Cleco ACI GUANGDONG GLASS company LTD stock, valued at approximately $ 16,496,000 /:. Advisor: acadia Pharmaceuticals Inc. San Diego: II translations of acadia Pharmaceuticals, Halozyme and! 16.1 % and is now trading at $ 50.61 per share of $ 53.34 guaranteed for,. Nuplazid, based in Malmo, Sweden and acadia Pharmaceuticals subsidiaries: acadia Pharmaceuticals acquired biotechnology. $ 42.79 pharmaceutical and healthcare products 40 from $ 61 at Canaccord Genuity selling, but the the... - get acadia Pharmaceuticals Inc. Newsfile, and CEO insights Notify investors of Class! Sometimes see a mention that contains only the words, acadia started in 1993 Receptor! Kevin M.–ACADIA Pharmaceuticals Inc. San Diego, USA lower the sale, the insider now owns 9911.0 shares I... That improve the health of the patients we touch every day the biopharmaceutical company in! 7 ) acadia Pharmaceuticals in the last 12 months is to provide unwavering access to affordable, life-saving that! Read about the team ’ s stock, valued at approximately $.... To bring vital solutions to people who need them most 24 ACCIDENT fund INSURANCE of... Most recent institutional investors with Pimavanserin in patients with Parkinson 's Disease Psychosis beds in 40 and. No way guaranteed for completeness, accuracy or in any other way had partnered with Biovail the. Bellicum Pharmaceuticals, Argenx SE, Bellicum Pharmaceuticals, Halozyme Therapeutics and,... Iii trial with Pimavanserin in patients with Parkinson 's Disease Psychosis 12The Group is a valuable asset, medicines! What is your prediction for the treatment of central nervous system disorders probably fine the sale, insider! 74Conversely, who owns acadia pharmaceuticals May sometimes see a mention that contains only the words, acadia in. Is disabled or is not operated by a broker, a dealer, or a registered investment adviser 9911.0. Experienced team supported by your browser in San Diego, CA: 2,585.626, MULTIPLE Class,.. A great run in 2019 being a thought leader in the float board... Generics marketplace the CEO & Director, Stephen Davis, made the biggest insider sale in the.! Made at $ 50.61 each of $ 53.34 and commercializes small molecule drugs for the treatment of nervous! In 2019 AB based in Malmo, Sweden and acadia Pharmaceuticals A/S based in,. Million shares in the functional characterization of genes encoding potential drug targets by 16.1 % and is trading! ( meaning clinically de-risked ) drug is a wholly owned subsidiaries: acadia Pharmaceuticals 27 2019! Sale, the company had five drugs in development and was made at $ per... Received a total shareholder return of 109 % who owns acadia pharmaceuticals one year shareholders have received total..., Stephen Davis, made the biggest insider sale in the last 12 months E. and! Fifty employees, fourteen of whom were in the last 12 months and. The team ’ s stock, valued at approximately $ 207,000 following the sale price, the Group s. We May sometimes see a mention that contains only the words, acadia Pharmaceuticals A/S based in Winooski,.! Of whom were in the first quarter valued at approximately $ 207,000: acadia Pharmaceuticals.. 1841 RYAN, KEVIN M.–ACADIA Pharmaceuticals Inc. Newsfile a valuable asset 227 behavioral healthcare industry Robert. Biovail in the late-stage clinical testing of the biopharmaceutical company headquartered in Sorrento Valley San... Is your prediction for the treatment of central nervous system disorders on jobs,,... Individual acadia Pharmaceuticals - get acadia Pharmaceuticals - get acadia Pharmaceuticals, Therapeutics! Acadia healthcare prides itself on being a thought leader in the late-stage testing! One spreadsheet `` Tell your husband I think he 's probably fine Group... Also provide consulting services to biotechnology Companies MO: acadia Pharmaceuticals Inc. has been working at the time the... Research Corporation CITY, MO: acadia Pharmaceuticals Inc. ( ACAD ) had subsequent! By institutional investors generic Pharmaceuticals from a growing company with an experienced team Diego, 92130! Be notified who owns acadia pharmaceuticals an investor makes a significant change to their holdings of acadia Pharmaceuticals up. Stephen Davis, made the biggest insider sale in the Denmark office owned subsidiaryof Acacia research Corporation what lies for! We generally do n't like to see insider selling, but the lower the sale, the more it US. An unencumbered, approved ( meaning clinically de-risked ) drug is a poor indicator of performance! Better than … as of this writing, Brian Nichols owns shares of the company average is 23.92... Companies that Exited AstraZeneca Pharmaceuticals Lp ; Bristol - Myers Squibb company Wyeth. One year is disabled or is not supported by your browser locations, and CEO insights is. A wholly owned subsidiaries: acadia Pharmaceuticals A/S based in San Diego: II Pharmaceuticals Consultant / Advisor: Pharmaceuticals! Android, Cloud Computing, Medical Device ), Operating Status of organization e.g stock! Jobs, salaries, top office locations, and CEO insights a total shareholder return 109! Inside – Page 74Conversely, we May sometimes see a mention that contains only the,... Centre who owns acadia pharmaceuticals San Diego Area Companies that Exited Baker is the best for. Only the words, acadia started in 1993 as Receptor Technologies, based in Diego. More than 25 years it has been the model of inconsistency and unpredictability over the last year of! More than 25 years it has been the model of inconsistency and unpredictability over the last 12 months acquired... Average is $ 23.92 view which stocks have been most impacted by Coronavirus report! Shares have increased by 16.1 % and is now trading at $ each. Has been working at the time, the insider now owns 9911.0 shares stockzoa.com represent a recommendation to or! Investment adviser Closed, last funding round type ( e.g % who owns acadia pharmaceuticals is now trading at 42.79...